Bristol-Myers Squibb Company (BMY) Upgraded to Buy at Argus Research
Rating Change Argus Research analysts upgraded Bristol-Myers Squibb Company (NYSE:BMY) from Hold to Buy on August 05, 2026. Market Context Bristol-Myers Squibb Company operates in…
Read more
